01.07.2005 | Original Articles
Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy
Erschienen in: Clinical and Translational Oncology | Ausgabe 6/2005
Einloggen, um Zugang zu erhalten